KSC:033270
Korea United Pharm Inc. · KSC · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:27 UTC
Last close
n/aKRW
Market data
6.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
8.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
13.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
9.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
2.6%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Growth is the furthest below its sector's middle: 0.47 against 0.47 on the market's range.
Follow one won
lens 1 of 9After what it costs to make
60.7%
After running the business
16.9%
After interest and tax
13.3%
After what it must reinvest
9.6%
Kept after the dividend
7.3%
The five stops
5 of 5 read- After what it costs to make175,407,516,00060.7%
- After running the business48,911,582,00016.9%
- After interest and tax38,308,011,00013.3%
- After what it must reinvest27,696,062,0009.6%
- Kept after the dividend21,075,991,0007.3%
Of every unit of sales, 0.07 is still there after the dividend.
Of every unit of sales, 0.07 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales288,764,868,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
After what it costs to make175,407,516,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
After running the business48,911,582,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
After interest and tax38,308,011,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
After what it must reinvest27,696,062,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Kept after the dividend21,075,991,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW